about
Dihydrofolate reductaseGTP cyclohydrolase 1Fc receptor, IgE, low affinity II, alpha polypeptideEstrogen receptor 1 (alpha)GTP cyclohydrolase 1Telomerase reverse transcriptaseProtein tyrosine kinase 2 betaNatriuretic peptide receptor 3Scavenger receptor class B member 1Telomeric repeat binding factor 2NUS1 dehydrodolichyl diphosphate synthase subunitNitric oxide synthase 1 adaptor proteinAngiotensin II receptor type 2AKT serine/threonine kinase 1Nucleotide binding oligomerization domain containing 1INSS100 calcium binding protein A1Apolipoprotein ENUS1 dehydrodolichyl diphosphate synthase subunitCalmodulin 35-hydroxytryptamine (serotonin) receptor 2BKirsten rat sarcoma viral oncogene homologThymoma viral proto-oncogene 1Natriuretic peptide receptor 3Angiotensin II receptor, type 2PTK2 protein tyrosine kinase 2 betaS100 calcium binding protein A1Scavenger receptor class B, member 1Nucleotide-binding oligomerization domain containing 1Calmodulin-1Telomeric repeat binding factor 2Tumor necrosis factor-likeCalmodulin 1Telomerase reverse transcriptaseNatriuretic peptide receptor 3GTP cyclohydrolase 1S100 calcium binding protein A1KRAS proto-oncogene, GTPaseProtein tyrosine kinase 2 betaAngiotensin II receptor, type 2
P682
Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylationHigh density lipoprotein binding to scavenger receptor, Class B, type I activates endothelial nitric-oxide synthase in a ceramide-dependent mannerAugmented BH4 by gene transfer restores nitric oxide synthase function in hyperglycemic human endothelial cellsInsulin-dependent activation of endothelial nitric oxide synthase is impaired by O-linked glycosylation modification of signaling proteins in human coronary endothelial cellsGTP cyclohydrolase I gene transfer augments intracellular tetrahydrobiopterin in human endothelial cells: effects on nitric oxide synthase activity, protein levels and dimerisationAngiotensin II stimulates endothelial NO synthase phosphorylation in thoracic aorta of mice with abdominal aortic banding via type 2 receptorGenetic aspects of inflammation and cancerApolipoprotein E inhibits platelet aggregation through the L-arginine:nitric oxide pathway. Implications for vascular diseaseDiscovery of common human genetic variants of GTP cyclohydrolase 1 (GCH1) governing nitric oxide, autonomic activity, and cardiovascular riskEndothelial miR-26a regulates VEGF-Nogo-B receptor-mediated angiogenesis.
P921
Q14819390-0763F362-5E6E-4923-9AD1-B5C049C54A72Q1487359-6C4D3355-7699-4AE5-B9AF-90F116EFED30Q14876571-EAD26F21-5B91-48E3-9831-C4F5BDDB402BQ14902317-5F768C95-E613-4BE9-8F84-58E29F4B6B38Q14916170-4FAD3EFD-4F38-4765-9D9B-5C3A6E831469Q15315162-0D041357-98E7-4FFE-8446-435CCB801537Q21101275-B1D2E878-5CCB-42CD-88E5-A83780B60208Q21105146-DA0C653A-52A2-44C2-8A72-3374A9F15BA6Q21108841-3F7CF861-9086-4E6F-812F-BC9A9A3E9390Q21109607-41CF059A-3732-4C0F-9C73-997F01E86CBCQ21110682-4A76FFE3-63EB-4C23-9946-12C56A3F31D0Q21112908-83669BDD-EBC4-4B8A-AA6F-9C37001EDF7BQ21113831-B0E46064-930A-4195-B6F8-E16866E7EBB0Q21114990-357ED382-92D9-49CA-A7AB-46D94753A776Q21124880-971ACDE1-F07C-4B6E-98D0-B669B7BA2AB0Q21163221-0261BC4E-636E-4B82-B478-CB55D561DE5CQ21171227-C13E8886-B864-44A9-9EB6-74B6900E0AD6Q21416505-D597CA43-58F1-4EDB-AE04-AB8597BFE43AQ21436461-9C9237D1-9FEA-4A06-976D-3AE4A0C4801AQ21494929-2C3154B3-0DC3-4F06-B47D-0EA0277D5A69Q21496043-3D04A445-BD8B-4B2B-953C-6D3AEBB3B347Q21498354-70854C2E-95C9-4444-9BFB-A9DB196C5EFFQ21498923-9130DCD0-76D7-4CBF-8227-F2AC9FDEF358Q21498977-A31F6D48-61A4-409A-9A8A-5D6F28D28724Q21983453-3F36E89F-1591-4388-A9CF-B9FA4C726EFAQ21985329-0C94B89B-6328-4F74-B682-D44CD96486E4Q21986749-303519B6-9724-4383-AE32-97622723ABFAQ21988081-0CA2070D-4882-4B6A-9A9E-87548A51D689Q21990357-B90E7630-C694-4C07-B8A8-0D3A61C6A61EQ22676983-0A465944-200C-44AC-8B51-F9A5FAF7A640Q22680121-D384B722-9B5D-4A32-97A4-C7F6325F3A3BQ28556072-A1F32FDF-62B4-436E-9397-CDBAC00F2543Q28556281-757F3B54-CCA3-43C9-9710-3CD1265FEFCAQ28557323-45C2968F-6EBA-468A-8354-F6D9A28AB50CQ28557506-B646DFC9-86B8-4C81-A111-B089AFDEA9BBQ28558105-4D5CC350-0758-43BF-A102-C6536E5152F5Q28558129-F6A5B38C-C7C5-4835-8B64-158DB22BD3ECQ28559548-180D5E90-475E-458F-B2FC-4EDE5B43B3A8Q28559587-1CDD81EA-182B-43FA-A16B-A4CC431FD171Q28560159-F81154BE-E0FD-4121-8AEC-135455CBEE6F
P682
Q22010150-7C0E17AE-B355-4738-A705-3B0BC46271C7Q24292170-F9D8BBC5-1364-4955-B8AC-6F972CABC958Q24295227-BB4D1ABB-0EC4-4DB9-ABB0-D59D1708ED77Q24301972-EF1469DE-953F-40FA-A728-C3329BE8754CQ24304352-17E5F59C-0F45-4159-BDE5-16B4DFA21FDBQ24304428-F02AEFF1-8F7A-46B9-917D-4074EFF2C7F9Q24311010-84FFF345-45C0-4B9D-A5DE-37BAF2C2FC88Q24312335-37C96AAD-AD33-42AC-BB8B-BE63BCBF4AE3Q24338261-36B6BCC4-2ABB-4A0A-80E8-CCAB398AE1E5Q41616135-27FBABF8-2CCC-4122-BF24-02BCA4F267C6
P921
description
Any process that activates or increases the activity of the enzyme nitric-oxide synthase.
@en
biologisch proces
@nl
name
positive regulation of nitric-oxide synthase activity
@en
type
label
positive regulation of nitric-oxide synthase activity
@en
altLabel
GO:0051000
@en
NOS activator
@en
nitric-oxide synthase activator
@en
positive regulation of NOS activity
@en
up regulation of nitric-oxide synthase activity
@en
up-regulation of nitric-oxide synthase activity
@en
upregulation of nitric-oxide synthase activity
@en
prefLabel
positive regulation of nitric-oxide synthase activity
@en
P2888
P686
GO:0051000